{"protocolSection":{"identificationModule":{"nctId":"NCT06119217","orgStudyIdInfo":{"id":"TTX-030-003"},"organization":{"fullName":"Trishula Therapeutics, Inc.","class":"INDUSTRY"},"briefTitle":"Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients","officialTitle":"An Open-Label Multicenter 3-Arm Randomized Phase 2 Study to Assess the Efficacy and Safety of TTX-030 and Chemotherapy With or Without Budigalimab, Compared to Chemotherapy Alone, for the Treatment of Patients Not Previously Treated for Metastatic Pancreatic Adenocarcinoma"},"statusModule":{"statusVerifiedDate":"2024-12","overallStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-03-25","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2027-02","type":"ESTIMATED"},"completionDateStruct":{"date":"2027-06","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-09-22","studyFirstSubmitQcDate":"2023-11-03","studyFirstPostDateStruct":{"date":"2023-11-07","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-12-02","lastUpdatePostDateStruct":{"date":"2024-12-04","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Trishula Therapeutics, Inc.","class":"INDUSTRY"},"collaborators":[{"name":"AbbVie","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without budigalimab in combination with chemotherapy (gemcitabine + nab-paclitaxel) in subjects with metastatic PDAC who did not have prior treatment for metastatic disease and are eligible to receive gemcitabine and nab-paclitaxel chemotherapy as SOC."},"conditionsModule":{"conditions":["Pancreatic Cancer"],"keywords":["Cancer","Pancreatic Adenocarcinoma","Combination Therapy","CD39","Adenosine Pathway","Immunotherapy","Immuno-oncology","Pancreatic Ductal Adenocarcinoma","PD-1 Checkpoint Inhibitor","Budigalimab","TTX-030","metastatic"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"Randomized, Parallel Group Study","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":194,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Arm 1","type":"EXPERIMENTAL","description":"TTX-030 plus nab-paclitaxel and gemcitabine","interventionNames":["Combination Product: TTX-030, nab-paclitaxel and gemcitabine"]},{"label":"Arm 2","type":"EXPERIMENTAL","description":"TTX-030 plus budigalimab plus nab-paclitaxel and gemcitabine","interventionNames":["Combination Product: TTX-030, budigalimab, nab-paclitaxel and gemcitabine"]},{"label":"Arm 3","type":"ACTIVE_COMPARATOR","description":"Nab-Paclitaxel and gemcitabine","interventionNames":["Combination Product: Nab-Paclitaxel and gemcitabine"]}],"interventions":[{"type":"COMBINATION_PRODUCT","name":"TTX-030, nab-paclitaxel and gemcitabine","description":"Dose and schedule per protocol","armGroupLabels":["Arm 1"]},{"type":"COMBINATION_PRODUCT","name":"TTX-030, budigalimab, nab-paclitaxel and gemcitabine","description":"Dose and schedule per protocol","armGroupLabels":["Arm 2"]},{"type":"COMBINATION_PRODUCT","name":"Nab-Paclitaxel and gemcitabine","description":"Dose and schedule per protocol","armGroupLabels":["Arm 3"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Progression-free survival (PFS) - Biomarker Enriched Population","description":"PFS is defined as the time from randomization until first documentation of progression or death from any cause, whichever occurs first","timeFrame":"Through study completion, an average of 1 year"}],"secondaryOutcomes":[{"measure":"Progression-free survival (PFS) - Overall Population","description":"PFS is defined as the time from randomization until first documentation of progression or death from any cause, whichever occurs first","timeFrame":"Through study completion, an average of 1 year"},{"measure":"Objective Response Rate (ORR)","description":"ORR is defined as the percentage of subjects who achieve best overall response (BOR) of either complete response (CR) or partial response (PR)","timeFrame":"Through study completion, an average of 1 year"},{"measure":"Duration of Response (DoR)","description":"DoR will be defined as the time from the first documentation of disease response (CR or PR) until first documentation of progression or death from any cause, whichever comes first.","timeFrame":"Through study completion, an average of 1 year"},{"measure":"Overall Survival (OS)","description":"OS is defined as the time from randomization until death due to any cause.","timeFrame":"Through study completion, an average of 1 year"},{"measure":"Adverse Events","description":"Type, severity, and frequency of treatment-emergent AEs","timeFrame":"Through study completion, an average of 1 year"}]},"eligibilityModule":{"eligibilityCriteria":"Abbreviated Inclusion Criteria:\n\n1. Age 18 years or older, is willing and able to provide informed consent\n2. Histologically or cytologically confirmed diagnosis of metastatic PDAC.\n3. No prior systemic treatment for metastatic disease.\n4. Evidence of measurable disease per RECIST 1.1.\n5. Appropriate for treatment with nab-paclitaxel and gemcitabine chemotherapy.\n6. Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1.\n\nAbbreviated Exclusion Criteria:\n\n1. History of clinically significant allergy or hypersensitivity to planned study treatment components or to any monoclonal antibody\n2. Use of investigational agent within 14 days prior to the first dose of study drug\n3. History of autoimmune disease\n4. Subject has received live vaccine within 28 days prior to the first dose of study drug\n5. Has uncontrolled intercurrent illness","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Investigative Site","city":"Tucson","state":"Arizona","zip":"85704","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"Investigative SIte","city":"Hot Springs","state":"Arkansas","zip":"71913","country":"United States","geoPoint":{"lat":34.5037,"lon":-93.05518}},{"facility":"Investigative Site","city":"Bakersfield","state":"California","zip":"93309","country":"United States","geoPoint":{"lat":35.37329,"lon":-119.01871}},{"facility":"Investigative Site","city":"Fullerton","state":"California","zip":"92835","country":"United States","geoPoint":{"lat":33.87029,"lon":-117.92534}},{"facility":"Investigative Site","city":"Los Angeles","state":"California","zip":"90095","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"Investigative Site","city":"Denver","state":"Colorado","zip":"80218","country":"United States","geoPoint":{"lat":39.73915,"lon":-104.9847}},{"facility":"Investigative Site","city":"St. Petersburg","state":"Florida","zip":"33705","country":"United States","geoPoint":{"lat":27.77086,"lon":-82.67927}},{"facility":"Investigative Site","city":"West Palm Beach","state":"Florida","zip":"33401","country":"United States","geoPoint":{"lat":26.71534,"lon":-80.05337}},{"facility":"Investigative Site","city":"Atlanta","state":"Georgia","zip":"30318","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Investigative Site","city":"Wichita","state":"Kansas","zip":"67214","country":"United States","geoPoint":{"lat":37.69224,"lon":-97.33754}},{"facility":"Investigative Site","city":"Baton Rouge","state":"Louisiana","zip":"70809","country":"United States","geoPoint":{"lat":30.44332,"lon":-91.18747}},{"facility":"Investigative Site","city":"Columbia","state":"Maryland","zip":"21044","country":"United States","geoPoint":{"lat":39.24038,"lon":-76.83942}},{"facility":"Investigative Site","city":"Burnsville","state":"Minnesota","zip":"55337","country":"United States","geoPoint":{"lat":44.76774,"lon":-93.27772}},{"facility":"Investigative Site","city":"Las Vegas","state":"Nevada","zip":"89119","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"Investigative Site","city":"Florham Park","state":"New Jersey","zip":"07932","country":"United States","geoPoint":{"lat":40.78788,"lon":-74.38821}},{"facility":"Investigative Site","city":"Asheville","state":"North Carolina","zip":"28806","country":"United States","geoPoint":{"lat":35.60095,"lon":-82.55402}},{"facility":"Investigative Site","city":"Columbus","state":"Ohio","zip":"43219","country":"United States","geoPoint":{"lat":39.96118,"lon":-82.99879}},{"facility":"Investigative Site","city":"Eugene","state":"Oregon","zip":"97401","country":"United States","geoPoint":{"lat":44.05207,"lon":-123.08675}},{"facility":"Investigative Site","city":"Portland","state":"Oregon","zip":"97239","country":"United States","geoPoint":{"lat":45.52345,"lon":-122.67621}},{"facility":"Investigative Site","city":"Horsham","state":"Pennsylvania","zip":"19044","country":"United States","geoPoint":{"lat":40.17844,"lon":-75.12851}},{"facility":"Investigative Site","city":"Austin","state":"Texas","zip":"78705","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"Investigative Site","city":"Dallas","state":"Texas","zip":"75246","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"Investigative Site","city":"San Antonio","state":"Texas","zip":"78258","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"Investigative Site","city":"Tyler","state":"Texas","zip":"75702","country":"United States","geoPoint":{"lat":32.35126,"lon":-95.30106}},{"facility":"Investigative Site","city":"Arlington","state":"Virginia","zip":"22205","country":"United States","geoPoint":{"lat":38.88101,"lon":-77.10428}},{"facility":"Investigative Site","city":"Norfolk","state":"Virginia","zip":"23502","country":"United States","geoPoint":{"lat":36.84681,"lon":-76.28522}},{"facility":"Investigative Site","city":"Roanoke","state":"Virginia","zip":"24014","country":"United States","geoPoint":{"lat":37.27097,"lon":-79.94143}},{"facility":"Investigative Site","city":"Milwaukee","state":"Wisconsin","zip":"53226","country":"United States","geoPoint":{"lat":43.0389,"lon":-87.90647}},{"facility":"Investigative Site","city":"Albury","state":"New South Wales","zip":"2640","country":"Australia","geoPoint":{"lat":-36.07482,"lon":146.92401}},{"facility":"Investigative Site","city":"Westmead","state":"New South Wales","zip":"2145","country":"Australia","geoPoint":{"lat":-33.80383,"lon":150.98768}},{"facility":"Investigative Site","city":"Herston","state":"Queensland","zip":"4029","country":"Australia","geoPoint":{"lat":-27.44453,"lon":153.01852}},{"facility":"Investigative Site","city":"Besan√ßon","zip":"25030","country":"France","geoPoint":{"lat":47.24878,"lon":6.01815}},{"facility":"Investigative Site","city":"Dijon","zip":"21079","country":"France","geoPoint":{"lat":47.31344,"lon":5.01391}},{"facility":"Investigative Site","city":"Lille","zip":"59000","country":"France","geoPoint":{"lat":50.63391,"lon":3.05512}},{"facility":"Investigative Site","city":"Paris","zip":"75013","country":"France","geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"Investigative Site","city":"Poitiers","zip":"86021","country":"France","geoPoint":{"lat":46.58261,"lon":0.34348}},{"facility":"Investigative Site","city":"Genova","zip":"16132","country":"Italy","geoPoint":{"lat":45.21604,"lon":11.87211}},{"facility":"Investigative Site","city":"Meldola","zip":"47014","country":"Italy","geoPoint":{"lat":44.12775,"lon":12.0626}},{"facility":"Investigative Site","city":"Milan","zip":"20132","country":"Italy","geoPoint":{"lat":42.78235,"lon":12.59836}},{"facility":"Investigative Site","city":"Pavia","zip":"27100","country":"Italy","geoPoint":{"lat":45.19205,"lon":9.15917}},{"facility":"Investigative Site","city":"Puglia","zip":"70124","country":"Italy","geoPoint":{"lat":43.5012,"lon":11.88261}},{"facility":"Investigative Site","city":"Verona","zip":"37134","country":"Italy","geoPoint":{"lat":45.43854,"lon":10.9938}},{"facility":"Investigative Site","city":"Goyang-si","zip":"10408","country":"South Korea","geoPoint":{"lat":37.65639,"lon":126.835}},{"facility":"Investigative Site","city":"Seongam","zip":"13496","country":"South Korea","geoPoint":{"lat":36.29295,"lon":127.57312}},{"facility":"Investigative Site","city":"Seongnam-si","zip":"13620","country":"South Korea","geoPoint":{"lat":37.43861,"lon":127.13778}},{"facility":"Investigative Site","city":"Seoul","zip":"03080","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Investigative Site","city":"Seoul","zip":"03722","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Investigative Site","city":"Seoul","zip":"05505","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Investigative Site","city":"Seoul","zip":"06351","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Investigative Site","city":"Seoul","zip":"08308","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Investigative Site","city":"Barcelona","zip":"08009","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Investigative Site","city":"Barcelona","zip":"08035","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Investigative Site","city":"Madrid","zip":"28040","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Investigative Site","city":"Madrid","zip":"28041","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Investigative Site","city":"Madrid","zip":"28050","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Investigative Site","city":"Majadahonda","zip":"28222","country":"Spain","geoPoint":{"lat":40.47353,"lon":-3.87182}},{"facility":"Investigative Site","city":"Pamplona","zip":"31008","country":"Spain","geoPoint":{"lat":42.81687,"lon":-1.64323}},{"facility":"Investigative Site","city":"Valencia","zip":"46009","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"Investigative Site","city":"Zaragoza","zip":"50009","country":"Spain","geoPoint":{"lat":41.65606,"lon":-0.87734}},{"facility":"Investigative Site","city":"Kaohsiung City","zip":"833401","country":"Taiwan","geoPoint":{"lat":22.61626,"lon":120.31333}},{"facility":"Investigative Site","city":"Taichung","zip":"40447","country":"Taiwan","geoPoint":{"lat":24.1469,"lon":120.6839}},{"facility":"Investigative Site","city":"Tainan","zip":"70403","country":"Taiwan","geoPoint":{"lat":22.99083,"lon":120.21333}},{"facility":"Investigative Site","city":"Taipei","zip":"112","country":"Taiwan","geoPoint":{"lat":25.05306,"lon":121.52639}},{"facility":"Investigative Site","city":"Taoyuan District","country":"Taiwan","geoPoint":{"lat":24.9896,"lon":121.3187}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-02-25"},"conditionBrowseModule":{"meshes":[{"id":"D010190","term":"Pancreatic Neoplasms"},{"id":"D009369","term":"Neoplasms"},{"id":"D009362","term":"Neoplasm Metastasis"}],"ancestors":[{"id":"D004067","term":"Digestive System Neoplasms"},{"id":"D009371","term":"Neoplasms by Site"},{"id":"D004701","term":"Endocrine Gland Neoplasms"},{"id":"D004066","term":"Digestive System Diseases"},{"id":"D010182","term":"Pancreatic Diseases"},{"id":"D004700","term":"Endocrine System Diseases"},{"id":"D009385","term":"Neoplastic Processes"},{"id":"D010335","term":"Pathologic Processes"},{"id":"D013568","term":"Pathological Conditions, Signs and Symptoms"}]},"interventionBrowseModule":{"meshes":[{"id":"C520255","term":"130-nm albumin-bound paclitaxel"},{"id":"D000093542","term":"Gemcitabine"},{"id":"C000719868","term":"budigalimab"}],"ancestors":[{"id":"D006571","term":"Heterocyclic Compounds"},{"id":"D003841","term":"Deoxycytidine"},{"id":"D003562","term":"Cytidine"},{"id":"D011741","term":"Pyrimidine Nucleosides"},{"id":"D011743","term":"Pyrimidines"},{"id":"D006573","term":"Heterocyclic Compounds, 1-Ring"}]}},"hasResults":false}